Westlake Omics

company

About

Westlake Omics focuses on applying mass spectrometry-based proteomics and other Omics technologies to address pressing clinical needs.

  • 11 - 50

Details

Last Funding Type
Seed
Industries
Artificial Intelligence,Biotechnology,Health Care,Medical
Founded date
Jun 1, 2020
Number Of Employee
11 - 50
Operating Status
Active

Westlake Omics focuses on applying mass spectrometry-based proteomics and other Omics technologies to address pressing clinical needs. It is committed to making breakthroughs in precision medicine and drug R&D with an unwavering focus on critical issues that impact life and health. This vision is driven by AI-empowered high-throughput proteomic analysis of minute amounts of clinical specimens and Omics technologies, supported by technological innovation and multi-modal big data.

It was founded in 2020 and is based in Hangzhou, Zhejiang, China.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Westlake Omics has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 13, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 13, 2022 Seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Westlake Omics is funded by 1 investors. Gaorong Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Gaorong Capital Seed